chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning a 25 year old female with asthma who on 05-FEB-2010 was vaccinated intramuscularly with her initial 0.5 ml PNEUMOVAX 23 (lot# 664478/1191Y).Concomitant therapies included thyroid medications and unspecified asthma medications. On 06-FEB-2010 the patient developed local redness and itching at the injection site. On 07-FEB-2010 the patient developed a fever of 103F. The patient had sought unspecified medical attention. Subsequently, on an unspecified date the patient recovered. Follow up information was received from the Licensed practical nurse concerning the 25 year old female with hypothyroidism, asthma and no known drug allergies, who on 05-FEB-2010 was vaccinated with the first dose of PNEUMOVAX 23 (IM, in the left deltoid) and the first dose of FLUZONE (IM, in the deltoid, Sanofi, UT3252AA). On 06-FEB-2010 the patient developed a large red circle at injection site which was itching. The patient also had a fever of 103F. Symptoms resolved between 11-FEB-2010 and 15-FEB-2010. Additional information is not expected.
Joint pain; got sicker than dog; Muscle pain; Headache; Chills; Dizzy; Slept 16 hours straight; This case was reported by a consumer and described the occurrence of joint pain in a 68-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included duloxetine hydrochloride (Cymbalta).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced joint pain, sickness, muscle pain, headache, chills, dizziness and sleep excessive. On an unknown date, the outcome of the joint pain, sickness, muscle pain, headache, chills, dizziness and sleep excessive were unknown.   It was unknown if the reporter considered the joint pain, sickness, muscle pain, headache, chills, dizziness and sleep excessive to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient taking blood pressure medication. The patient received 2nd dose of Shingrix and experienced sicker than dog, all joints and muscles  hurt, bad headache,chills, dizzy, slept 16 hours straight The patient asked is this normal after the 2nd shot.
Information has been received from a registered nurse concerning 3 female patient who were vaccinated with a 0.5 mL third dose of GARDASIL, intramuscularly. The patients tested positive for HPV later. The patients had a colposcopy. The patients sought unspecified medical attention. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
The day after I got my second shot a big red spot appeared a couple inches below the injection location on my right shoulder. It was about the size of my fist, was asymetrical, blotchy, slightly swollen, and hot to the touch. The next day it was bigger-about the size of my open hand, and still red, hot, swollen and blotchy.
Patient involved in near-vasovagal syncopal episode was at front of store when event happened. Pt was able to sit in chair and not fall or lose consciousness. Prior to event, patient was instructed by provider to wait in waiting room for 15 mins for observation. After 15 mins passed receiving vaccination, patient states that she was feeling good and did not have any symptoms. Provider was in the clinic after being notified by pharmacist that a patient "fainted."  During patient's recovery, provider took vitals of patient, all which were within normal limits. Provider stayed with patient until she fully recovered and observed her for any additional symptoms. At approx 1828, patient was able to ambulate to outside the store, where provider & patient awaited pt's father to retrieve car. Pt continuously stated that she was feeling better. A follow-up call will be scheduled to check on patient tomorrow.
2/11/21 (9 days after receiving vaccine), I woke in the morning to a sore left arm. Large area on upper arm was reddened, swollen, slightly raised and itchy. This was not directly at the site of the injection but several inches lower.  All these symptoms remained for 24 hours, with only the redness remaining for a total of approximately 48-60 hours after initial onset.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day as Moderna COVID-19 Vaccine to the patient. It was unknown if patient received other vaccines within one month prior to any dose of Moderna COVID-19 Vaccine.     On 18-Feb-2022 at 6:42 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Feb-2022 at 6:42 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had received booster dose.  No concomitant drug information was provided.  The  30 days Expiry date vaccine went into 2 to 8 °C thaw state on or about to 20-Dec-2021, this vaccine administered until its Mfg date of 04-Apr-2022  No treatment drug information was received.   This case was linked to MOD-2022-542869 (Patient Link).
After vaccination, noticed swollen lymph nodes on left side of neck near clavicle that were not swollen before. I was advised by a doctor that I should expect them to return to normal in a few weeks, but the lumps are still there and have not gone down much at all. It seems to be a mostly cosmetic issue but is bothersome nonetheless.
arthralgia; fatigue; insomnia; soreness at site of injection; swollen lymph nodes on left anterior clavicular region; Fever (99.9 at highest); chills; first dose was received on 27Dec2020/2nd dose on 13Jan2021; This is a spontaneous report from a contactable healthcare professional (patient). A 44-year-old female received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3302 and expiry date:May2021), via an unspecified route of administration on the left arm on 13Jan2021 13:30 at single dose for covid-19 immunisation. The first dose was received on 27Dec2020 13:30 on the left arm, Medical history included hypertension, anxiety, GERD (gastrooesophageal reflux disease) and insomnia. Concomitant medication included atenolol, omeprazole (PRILOSEC), hydroxyzine hydrochloride (VISTARIL) and unspecified multivitamins. The patient previously took neomycine and experienced drug hypersensitivity. The patient experienced fever (99.9 at highest), chills, arthralgia, fatigue, insomnia, soreness at site of injection, swollen lymph nodes on left anterior clavicular region on 14Jan2021 05:45. No treatment was given for the events. Outcome of the events was recovering. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The reporter considered the events non-serious.
Pt stated she was hot prior to injection.one minute after left deltoid injection she stated that she did not feel well and went into syncope, eyes rolled back and we supported the upper body from falling while audibly calling for assistance. patient responded after 30 seconds. Maneul blood pressure was 90/60 heart rate was 64 with regular tone. Lungs were clear. she was also alert and oriented but drowsy.she stated she did not want to go to the hospital but we thought to be in her best intrest to call 911. We called 911 and they arrived within 5 minutes and took over. patient was taken to the hospital and we did contact a sister to let her know.
Moderna COVID-19 Vaccine EUA.  About 5 hours after vaccination I noticed red lines across the tops of my eyelids. It looked like someone had scratched a across the lids.  My skin felt irritated and the lids of my eyes started to swell. The swelling was not enough that I couldn?t open my eyes but my lids felt very heavy.  I could feel the skin was raw and raised where I could see the red line. It look at least 4 days to the swelling to completely go away.
Drug ineffective; had her first dose and tested positive; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that (reporting for herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was vaccinated with the first dose and tested positive. She was scheduled to have 2nd dose on 09Mar2021 and based on the information given to her, there should be a 30days interval before getting the 2nd shot if someone tested positive for Covid (drug ineffective and covid-19). She would like to confirm if that information is correct. The patient underwent lab tests and procedures which included sars-cov-2 antibody test and was positive on unspecified date. Case considered as serious (medically significant). Outcome of the events was unknown.
Swollen lymph nodes under arm pit in the injected arm and at times painful.  The injections site is still tender and swollen.
This spontaneous report as received from a consumer refers to a 63 year old female patient who reports on herself. The patient had no allergies. No information regarding the patient's medical history and concomitant medications was provided. In January 2016 (reported as about one month ago), the patient was vaccinated with the dose of ZOSTAVAX injection, in the left arm (dose, route of administration, lot# and expiration date were not reported). In 2016 (2 weeks post vaccination), the patient developed on her left leg red circles, warm to the touch. The circles were the size of a pencil head or smaller. The circles were below the left knee, but above the left ankle. The circles went away 5 or 6 days later by themselves with no treatment (unspecified date in 2016). Then 2 weeks later (approximately in February 2016), the patient developed what she stated looked like bug bites/bumps on the right underarm, at the fatty part. The patient sought medical attention and was seen by her dermatologist. The physician had questioned her if she had gotten the ZOSTAVAX vaccine. When she replied yes, the dermatologist took a scraping biopsy of one of the bumps. The event was treated with HALOG cream. The outcome of bug bites/bumps on the right underarm was reported as not recovered. The outcome of red circles, warm to the touch was assessed as recovered. The causality between the adverse event and ZOSTAVAX was not provided. Additional information has been requested.
could barely walk; when he puts pressure on right leg it now hurts from knee to buttocks; chills; muscle aches; Felt cold; This spontaneous case was reported by a consumer and describes the occurrence of   in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Diabetes and Peanut allergy. Concomitant products included CHLORIDE for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Fever 103 , chills, headache, muscle pain, nausea, rash, hives, dizziness , right part face swelling, left hand and leg tingling and numb sensation, vomit  with fever.
DEVELOPED FREQUENT PVCs(PREMATURE VENTRICULAR CONTRACTIONS), VENTRICULAR TACHYCARDIA, ABNORMAL EKG,   ECG 04/05/2022 24 HOUR HOLTER MONITOR 04/11/2022 ECHO W/O CONTRAST 04/22/2022 NM CARDIAC PERF STRESS TEST 05/11/2022 CONDITIONS CONFIRMED WITH DR (ELECTROPHYSIOLGIST)   TREATMENT: STARTED TAKING METOPROLOL 25 mg DAILY
Pt recvd 3 doses of Engerix-B on 26NOV90, 226DEC90, & 26MAY91 & had no post screening, but was checked 1 yr later & was neg, having low titers;
In approximately May or June 2000, two patients had titers drawn. Both patients were seronegative for varicella immunoglobulin. Unspecified medical attention was sought. Additional information has been requested.
I63.9 - CVA (cerebral vascular accident) (CMS/HCC) I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC
Left upper arm with pink swelling approximately 3"x4" in size, no induration, using arm normally, no apparent pain or itch. Symptoms occurred in 1st 24 hours after vaccine.
a 17-year-old patient received a dose of Infanrix on 29/Mar/2023; a 17-year-old patient received a dose of Infanrix on 29/Mar/2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 17-year-old male patient who received DTPa (Infanrix) (batch number 7HM5J, expiry date 13-SEP-2024) for prophylaxis.   On 29-MAR-2023, the patient received Infanrix. On 29-MAR-2023, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: a 17-year-old patient received a dose of Infanrix on 29/Mar/2023) and inappropriate schedule of vaccine administered (Verbatim: a 17-year-old patient received a dose of Infanrix on 29/Mar/2023).  The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Receipt date: 22-Aug-2023 The pharmacist called to informed that the patient received a dose of Infanrix as 3rd dose of the series at an inappropriate age, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.  The reporter consented to follow-up.
Head ache.  Vomiting.  Loss of urine control.  Weakness.  Loss of stability  -  falling down.  Fever - 101.3.  - Not wanting to eat.  Not much coordination. Fatigued.  Chills and sweats. Wheezing. Chest congestion.  Coughing.
102.6 fever for 6 hrs, took acetaminophen after calling NP at 6pm, resolved by 8 pm (to 99). Swelling, redness, pain of entire arm 3in (7.5 cm) BELOW injection site, resolved after 3 days (no pain or swelling at injection site). Shoulder stiffness, resolved after 3 days. Fatigue, loss of appetite, queasy stomach, resolved after 3 days.
few minutes after the patient had the vaccine, he felt dizzy, start sweating, his face and lips looked pale. we gave him water and snack, then he felt fine. this just last 5 minures.
patient stated had redness around injection site for 1 to 2 days after administration. redness went away and then redness/rash returned 1 week later, approximately 2 to 3 inches in diameter. patient stated area had mild itching, but denied warm to touch. Patient stated itching was brief, did not last long.
Patient presented with redness and itching in right arm where vaccine was injected and along inside of arm.
Pt experienced cardiac palpitations the day after Menactra was given. Normal EKG at the time was evaluated. Currently having follow up with cardiac event monitor.
Associate presented to employee health office on 10/26/09 at 930 AM stated after receiving H1N1 vaccine on 10/23 "didn't feel well" was told on Saturday at kids birthday party by a physician friend that she has facial drooping, Guillain Barre & should go home & rest. States today she has bilateral facial numbness. Received seasonal Flu vaccine on 9/15/09. Seen again in office 10/27/09 Bilat LE numbness tingling. Appointment made with neurologist. 10/28/09:  ED Records received for date of service 10/26/09, Medical Record received for date of service 10/28/09.   Assessment:  Presented with 3 day history of numbness on both sides of the face to ED, two days later seen and noted very mild tingling in both legs. Unable to close eyes completely.  Arms and legs feel weak.  No difficulty chewing or swallowing.  Unable to walk up or down stairs.  Wide based gait. Presentation suspicious for AIDP/GBS.   Labs and Diagnostics:  Pending.  11/5/2009 records for 10/28/2009, patient with c/o's progressive weakness, facial numbness, rt facial droop. Tx: toradol Iv, observation, LP.  Patient was seen 10/28/2009 at 10:45sm by neurologist for bilateral facial numbness. Patient is now being sent to hospital for further testing. 12/3/09 DC summary and medical records received for dates 10/28/09 to 11/2/09. DX: generalized weakness, post LP HA. Pt was transferred to hosp. w/ h/o POTS syndrome, c/o LE weakness, then facial numbness after H1N1 vax on 10/23. On 10/25 pt. c/o whole body tingling that progressively worsened. Pt was eval. At local ER and dc. On 10/28 pt f/u w/ neurologist was referred back to hosp. for direct admission with symptoms consistent w/ GBS according to pt. neurologist. Later was reassessed and neurologist felt not consistent with GBS. Pt improved over course of stay. DC stable.
ABOUT 1 YEAR AFTER RECEIVING THE SHOT, SHE STARTING COMPLAING ABOUT JONT PAIN, NUMBING AND TINGLING.. EARACHES. THE JOINT PAIN BECAME VERY WORSE. SHE COULDNT EVEN GET OUT OF BED B Y THE TIME SHE WAS 16. SHE HAS BEEN TESTED FOR EVERYTING. LYME DISEASE, TICK DISEASE, MRI, CAT SCAN, SEEN 2 SPECIALIST. AS OF 2 YEARS AGO SHE NOW HAS 3 ABNORMAL PAPS, SHE HAS MILD DYSPLASIA, CYSTS ON HER OVARIES. IRREGULAR PERIODS, AND CHRONIC PELVIC PAIN. MY ELDEST DAUGHTER WHO DID NOT GET VACCINATED AND IS PERFECTLY HEALTHY.
14FEB92 inject site & arm red & sl swollen fever 99-100.6; Seen in ER; 16FEB92 fever & heart palpitations; EKG-OK sent home;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient wanted to know how to get rid of the pain from the injection site from the shingles vaccine.
Patient received his first administration of GARDASIL 9 at the age of 26 and has not received the rest of recommended doses; No additional adverse events reported; This spontaneous report was received from a pharmacy intern, referring to a 32 year old male patient. The patient's medical history, concurent conditions, and concomitant medications were not reported.  On an unknown date (reported as at the age of 26), the patient was vaccinated with the first and only hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route, anatomical location, lot #, and expiration date were not provided) for prophylaxis. At the time of the report, the patient had not received the rest of the recommended doses (Inappropriate schedule of product administration). No additional adverse events were reported.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: HE GOT DIZZY FOR A SECOND AND FELL DOWN, GOT UP IN A SECOND. HE WAS SWEATING LITTLE BIT. OFFERED HIM TO REST FOR 15-20 MIN AND GAVE WATER. AND OFFERED TO CALL SOMEONE OR EMS (DECLINED).
After receiving the vaccine the injection site was sore and continued to worsen.  It started to swell up and became very painful.  Within a few hours I was limited in movement of that arm.  By the following morning it was large, very painful and I was unable to move my arm.   This continued for the next 4-5 days. The last 2 days I was placing a heating pad on the arm.
chest pain; fever; body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea). At the time of the report, CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature: 101.9 (High) High.         No concomitant medication were used. No treatment medication were used.
FAINTNESS/FELT LIKE PASSED OUT; DIFFICULTY EATING; RED MARK/DOT ON VACCINATED ARM; JOINT SORENESS; MUSCLE SORENESS; NAUSEA/FELT TO VOMIT WHILE EATING; HEADACHE; This spontaneous report received from a patient concerned a 40 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced throat swelled up when treated with amoxicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 25-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 26-MAY-2021, the subject experienced faintness/felt like passed out. On 26-MAY-2021, the subject experienced difficulty eating. On 26-MAY-2021, the subject experienced red mark/dot on vaccinated arm. On 26-MAY-2021, the subject experienced joint soreness. On 26-MAY-2021, the subject experienced muscle soreness. On 26-MAY-2021, the subject experienced nausea/felt to vomit while eating. On 26-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea/felt to vomit while eating, joint soreness, headache, faintness/felt like passed out, red mark/dot on vaccinated arm, difficulty eating, and muscle soreness. This report was non-serious.
Pain in right leg since evening of injection. Got rash 1 week after injection on right buttock . Found to have shingles when saw pmd today